Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 1,250 shares at $18.40 ($23K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Scheduled sale ($23k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.33 | 371 | $7K | 29.6% |
| 2 | $18.40 | 879 | $16K | 70.4% |
| Total | $18.38 avg | 1,250 | $23K | 100% |
| Filing → |
| PCRX | SELL | 2025-11-19 | $191K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |
| PCRX | SELL | 2024-07-03 | $80K | — | Filing → |